Related Experiment Video
Updated: Aug 23, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Evaluation of platelet activation, plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients
Małgorzata Tomczykowska1, Janusz Bielak, Artur Bodys
1Department of Internal Diseases and Endocrynology Cardinal Stefan Wyszyński Specialist Hospital in Lublin, Lublin, Poland.
The aim of the study was to evaluate the degree of platelet activation and plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients. The studied group consisted of 21 patients with hypertension. The control group included 19 healthy volunteers. The values of platelet and plasma coagulation factors were determined using the synthetic chromogenic substrates and the spectrophotometric method. Compared to the healthy individuals, the hypertensive patients show increased platelet activity confirmed by a statistically significant increase in the platelet factor 3 activity, which is likely to intensify the plasma proaggregation and procoagulation activities. In the hypertensive patients, a significant decrease in antithrombin III (the endogenous inhibitor of the coagulation system) concentration is observed. In arterial hypertension, a significant decrease in alpha2-antiplasmin activity is found, which may reflect decreased fibrinolytic activity of plasma in the hypertensive patients.
The aim of the study was to evaluate the degree of platelet activation and plasma antithrombin III and alpha2-antiplasmin activities in hypertensive patients. The studied group consisted of 21 patients with hypertension. The control group included 19 healthy volunteers. The values of platelet and plasma coagulation factors were determined using the synthetic chromogenic substrates and the spectrophotometric method. Compared to the healthy individuals, the hypertensive patients show increased platelet activity confirmed by a statistically significant increase in the platelet factor 3 activity, which is likely to intensify the plasma proaggregation and procoagulation activities. In the hypertensive patients, a significant decrease in antithrombin III (the endogenous inhibitor of the coagulation system) concentration is observed. In arterial hypertension, a significant decrease in alpha2-antiplasmin activity is found, which may reflect decreased fibrinolytic activity of plasma in the hypertensive patients.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care